Overview

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
A Study of Albuferon with Ribavirin in Interferon Alfa Naive Subjects with Chronic Hepatitis C Genotype 2 or 3.
Phase:
Phase 2
Details
Lead Sponsor:
Human Genome Sciences Inc.
Treatments:
Interferon-alpha
Interferons
Ribavirin